Jan 1 - Jan 1
Weekly NIH Funding Opportunities and Notices for June 13, 2025 Policy Notices
Intramural Funding

Weekly NIH Funding Opportunities and Notices for June 13, 2025
Policy Notices
- Notice of Rescission of Civil Rights Term and Condition of Award (NOT-OD-25-124) National Institutes of Health
General Notices
- Temporary Extension of Eligibility for the NIH Pathway to Independence Award (K99/R00) (NOT-OD-25-121) Office of the Director, NIH
- Request for Information (RFI): Better Tools to Predict Toxicities Resulting from Oligonucleotide Therapeutics (NOT-TR-25-011) National Center for Advancing Translational Sciences
Funding Opportunities
-
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) (PA-25-422) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute
-
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) (PA-25-425) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute
-
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) (PA-25-426) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute
-
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) (PAR-25-414) National Institute of General Medical Sciences National Cancer Institute
-
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) (PAR-25-415) National Institute of General Medical Sciences National Cancer Institute
-
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) (RFA-RM-25-001) National Institutes of Health
- NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) (RFA-RM-25-002) National Institutes of Health